Related Experiment Video
Updated: Jan 15, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Antibody-Positive Type 1 Diabetes in a Family With a Pathogenic HNF1A-MODY Variant and Variable Age of Onset
Michael E McCullough1, Anisa M Dye1, Balamurugan Kandasamy1
1Section of Adult and Pediatric Endocrinology, Diabetes and Metabolism and Kovler Diabetes Center, University of Chicago, Chicago, IL 60637, USA.
Abstract:
Monogenic diabetes (MD) is a relatively rare and heterogeneous group of disorders caused by pathogenic single-gene variants or abnormalities resulting in hyperglycemia. MD represents approximately 3.5% of all diabetes cases diagnosed before age 35 years, though it is possible for MD to develop at later ages. MD diagnoses have implications for precision therapy and cascade genetic testing. A hallmark characteristic suggesting MD is a multigenerational family history of nonobese diabetes diagnosed before age 35 with an autosomal dominant inheritance. However, even with a known family history of genetically confirmed MD, it is possible for an individual within that family to have a different form of diabetes. Here, we present a case from the University of Chicago Monogenic Diabetes Registry of an individual with antibody-positive type 1 diabetes in a family with a history of a genetically confirmed known pathogenic HNF1A variant causing maturity-onset diabetes of the young (MODY) with variable age of onset in affected individuals. This family pedigree showcases that HNF1A-MODY can develop at any age and illustrates the importance of every individual receiving a thorough work-up for accurate diabetes classification, including obtaining antibody testing and genetic testing, when indicated, to provide optimal treatment and management.
Insights
Monogenic diabetes (MD) can present atypically. Even in families with known HNF1A variants, individuals may have antibody-positive type 1 diabetes, highlighting the need for comprehensive testing.
Area of Science:
- Genetics
- Endocrinology
- Metabolic Disorders
Background:
- Monogenic diabetes (MD) is a rare, heterogeneous group of disorders caused by single-gene variants leading to hyperglycemia.
- MD accounts for about 3.5% of diabetes cases diagnosed before age 35, but can occur later in life.
- Accurate MD diagnosis is crucial for personalized therapy and genetic screening.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Pedigree Analysis
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...

